Drägerwerk AG & Co. KGaA (DRW8) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Drägerwerk AG & Co. KGaA (DRW8) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€74.80 Million ≈ $87.45 Million USD) by net assets (€1.51 Billion ≈ $1.76 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Drägerwerk AG & Co. KGaA - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Drägerwerk AG & Co. KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Drägerwerk AG & Co. KGaA for a breakdown of total debt and financial obligations.
Drägerwerk AG & Co. KGaA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Drägerwerk AG & Co. KGaA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
VITZROCELL Co.Ltd
KQ:082920
|
0.016x |
|
Guangzhou KingTeller Technology Co Ltd
SHE:002177
|
0.006x |
|
Global Top E Commerce Co Ltd
SHE:002640
|
-0.466x |
|
Shenzhen Sunxing Light Alloys
SHG:603978
|
-0.074x |
|
Prima Andalan Mandiri Tbk PT
JK:MCOL
|
0.113x |
|
STEVANATO GROUP SPA O.N.
F:87N
|
0.063x |
|
Zhejiang Shengyang Science
SHG:603703
|
0.010x |
|
Shanxi Zhendong Pharmaceutical
SHE:300158
|
-0.055x |
Annual Cash Flow Conversion Efficiency for Drägerwerk AG & Co. KGaA (2005–2024)
The table below shows the annual cash flow conversion efficiency of Drägerwerk AG & Co. KGaA from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see DRW8 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €1.54 Billion ≈ $1.80 Billion |
€167.31 Million ≈ $195.60 Million |
0.109x | -19.11% |
| 2023-12-31 | €1.41 Billion ≈ $1.65 Billion |
€189.68 Million ≈ $221.75 Million |
0.135x | +223.13% |
| 2022-12-31 | €1.32 Billion ≈ $1.54 Billion |
€-144.23 Million ≈ $-168.62 Million |
-0.109x | -135.80% |
| 2021-12-31 | €1.26 Billion ≈ $1.47 Billion |
€384.89 Million ≈ $449.97 Million |
0.305x | -31.37% |
| 2020-12-31 | €1.03 Billion ≈ $1.21 Billion |
€459.98 Million ≈ $537.76 Million |
0.445x | +191.27% |
| 2019-12-31 | €1.08 Billion ≈ $1.26 Billion |
€164.42 Million ≈ $192.22 Million |
0.153x | +3936.11% |
| 2018-12-31 | €1.08 Billion ≈ $1.26 Billion |
€4.09 Million ≈ $4.78 Million |
0.004x | -97.18% |
| 2017-12-31 | €1.07 Billion ≈ $1.25 Billion |
€143.34 Million ≈ $167.57 Million |
0.134x | -31.07% |
| 2016-12-31 | €1.00 Billion ≈ $1.17 Billion |
€195.32 Million ≈ $228.35 Million |
0.195x | +361.89% |
| 2015-12-31 | €945.93 Million ≈ $1.11 Billion |
€39.86 Million ≈ $46.60 Million |
0.042x | -79.90% |
| 2014-12-31 | €896.61 Million ≈ $1.05 Billion |
€187.98 Million ≈ $219.77 Million |
0.210x | +150.33% |
| 2013-12-31 | €815.97 Million ≈ $953.95 Million |
€68.34 Million ≈ $79.90 Million |
0.084x | -65.54% |
| 2012-12-31 | €727.20 Million ≈ $850.17 Million |
€176.75 Million ≈ $206.64 Million |
0.243x | +10.90% |
| 2011-12-31 | €729.62 Million ≈ $853.00 Million |
€159.91 Million ≈ $186.95 Million |
0.219x | -36.34% |
| 2010-12-31 | €636.56 Million ≈ $744.21 Million |
€219.14 Million ≈ $256.20 Million |
0.344x | -29.92% |
| 2009-12-31 | €393.82 Million ≈ $460.42 Million |
€193.45 Million ≈ $226.17 Million |
0.491x | +160.88% |
| 2008-12-31 | €517.64 Million ≈ $605.18 Million |
€97.47 Million ≈ $113.95 Million |
0.188x | -39.66% |
| 2007-12-31 | €505.49 Million ≈ $590.97 Million |
€157.75 Million ≈ $184.42 Million |
0.312x | +88.90% |
| 2006-12-31 | €539.99 Million ≈ $631.31 Million |
€89.21 Million ≈ $104.29 Million |
0.165x | +41.12% |
| 2005-12-31 | €257.68 Million ≈ $301.25 Million |
€30.16 Million ≈ $35.27 Million |
0.117x | -- |
About Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more